Jeff Simmons

Jeff Simmons, the President and CEO of Elanco Animal Health, shares insights on the company's recent stock surge following impressive second-quarter results. He discusses the launch of innovative dog medications, including Credelio Quattro and Zenrelia, designed to address canine health challenges. Simmons also dives into Elanco's strategic framework aimed at sustainable value creation and the significance of American manufacturing in the animal health sector. The conversation highlights the balance between personal connections with pets and business growth opportunities.